Spyre Therapeutics grants inducement equity awards to four new hires at $94.93 strike price
SYRE•Option and RSU vesting terms
The options carry a 10-year term and a $94.93 exercise price. They vest 25% after one year, then monthly.
The RSUs vest in four equal annual installments tied to the next Feb. 15, May 15, Aug. 15 or Nov. 15 after the start date.
Inducement equity awards for four new hires
Spyre Therapeutics granted inducement equity awards to four non-executive employees under its 2018 Equity Inducement Plan.
Awards cover stock options for 19,436 shares and restricted stock units for 6,186 shares; both were granted Aug. 3.
